Bioterrorism Awareness: Protection of Human and Animal Health - PowerPoint PPT Presentation

1 / 118
About This Presentation
Title:

Bioterrorism Awareness: Protection of Human and Animal Health

Description:

Bioterrorism Awareness: Protection of Human and Animal Health – PowerPoint PPT presentation

Number of Views:167
Avg rating:3.0/5.0
Slides: 119
Provided by: center70
Category:

less

Transcript and Presenter's Notes

Title: Bioterrorism Awareness: Protection of Human and Animal Health


1
Bioterrorism AwarenessProtection of Human and
Animal Health
  • Food animal veterinarians

2
Why Are We Here?
  • September 11, 2001 changed many things
  • Worst terrorist act in U.S. history
  • More than 3000 presumed dead
  • Occurred on American soil
  • Increased sense of vulnerability

3
Biological Attack
  • Bioterrorism attacks of 2001
  • Anthrax in postal system
  • 22 cases
  • 5 deaths
  • U.S. public health realm changed forever

4
Preparedness Responsibilities Veterinarians
  • Anticipate outbreaks on the local level
  • Collect and label samples
  • Know the agents
  • Know the typical signs of diseases
  • Animals and human
  • Know how to report suspected cases
  • Disseminate knowledge

5
Overview
  • Bioterrorism
  • Zoonoses and bioterrorism
  • Disease control and biosecurity
  • U.S. Government agencies involved
  • Bioterrorism agents/diseases
  • Your role and responsibility

6
Terrorism
  • Biological, chemical, or radiological agents
    targeting agriculture or its components
  • Livestock
  • Food supply
  • Crops
  • Industry
  • Workers
  • Conventional, radiological, nuclear,
    chemical,cyber
  • Typically direct human targeting

Biological agents targeting humans, animals, or
plants
7
Characteristics of a Biological Attack
  • Difficult to detect release
  • Dissemination may cover large area
  • Possible secondary spread
  • Recognition of agent may be delayed days to weeks
  • Difficulties in catching perpetrator

8
Infectious Disease Outbreak
Time (Days)
9
Clues Suggesting Biological Agent Release
  • Clustering of morbidity or mortality
  • Temporally or geographically
  • Large numbers of animals and/or people
  • Atypical symptoms
  • Normally healthy people affected
  • Unusual symptoms for area
  • Unusual age distribution
  • Disease occurring outside typical season

10
Many Agents are Zoonotic
  • Disease may be seen in animals before humans
  • Animals are sentinels
  • Pets, livestock,
    wildlife

11
Factors That Promote Transmission of Zoonoses
  • Frequent contact with domestic or wild animals
  • Overlap with wildlife habitat
  • Intensive livestock production
  • Poor animal sanitation
  • Poor personal hygiene
  • Poor animal health

12
Disease Control Client Education
  • Disinfect/clean up areas contaminated with animal
    waste
  • Livestock, pets, wildlife, rodents
  • Basic hygiene
  • Wash hands
  • Child supervision

13
Zoonoses ControlClient Education
  • Proper pet selection
  • Avoid petting zoos
  • Cook food properly
  • Control strays
  • Communication with physician and veterinarian
  • Follow guidelines for immunocompromised people

14
Biosecurity Educationfor the Producer
  • Develop and implement a biosecurity plan
  • Train employees to help maintain the plan
  • Post signs restricting access to areas of the
    farm and control traffic flow

15
Biosecurity Educationfor the Producer
  • Regulate visitors
  • Keep visitors sanitary
  • Clean clothing, boots
  • Disposable plastic
    shoe/boot covers
  • Implement insect, bird, and animal control
  • Secure water, feed and nutrient sources

16
Biosecurity Educationfor the Producer
  • Maintain healthy herd
  • Vaccinate
  • Proper hygiene for animals and handlers
  • Purchase from reputable sources
  • Quarantine newly purchased animals
  • Separate sick animals

17
Biosecurity Veterinarians
  • Disinfect your clothes, boots, equipment between
    farms
  • Avoid vehicle contamination
  • Follow biosecurity guidelines set forth by
    species specific associations

18
U.S. Agencies
  • Dealing with terrorism

19
Public Health Security and Bioterrorism
Preparedness Response Act of 2002
  • June 12, 2002
  • Improve ability of the U.S. to prevent, prepare
    for, and respond to bioterrorism and other public
    health emergencies
  • 4.3 billion
  • 1.6 billion to state, local governments
  • 300 million to CDC
  • 1.15 billion to Secretary HHS
  • 190 million for agriculture bioterrorism RD
  • 160 million for water protection

20
Department of Homeland Security
  • Homeland Security Act of 2002
  • Mission
  • Prevent, protect, and respond to acts of
    terrorism on U.S. soil
  • Four divisions
  • Border and Transportation Security
  • Emergency Preparedness and Response
  • Chemical, Biological, Radiological and Nuclear
    Countermeasures
  • Information Analysis and Infrastructure
    Protection

21
Centers for Disease Control and Prevention
  • CDC's Mission
  • Promote health and quality of
    life by preventing and
    controlling disease, injury,
    and disability
  • Preparing for bioterrorism since 1998
  • One of first agencies to respond to anthrax
    incidents

22
Strategic National Stockpile
  • 12-hour Push Package
  • Complete package of medical materials
  • Vendor Managed Inventory
  • Tailored to suspected agents

23
Insert Your States Info Here
24
Preparing Iowa
  • Iowas Homeland Security www.iowahomelandsecurity.
    org
  • Administered by Iowa Emergency Management
    Division
  • Preparedness, mitigation, response and recovery
  • Works with public and private partners
  • Detection, protection, and prevention

25
Preparing Iowa
  • Iowa Department of Public Health
    www.idph.state.ia.us/odedp
  • Iowa Department of Agriculture and Land
    Stewardship
  • Highly infectious animal disease program
  • IRVIN Iowa Rapid Vet Info Network
  • CFSPH training veterinarians to educate others

26
Category ABC Agent Overview
27
Classification
  • Prepared by the CDCs Bioterrorism Preparedness
    and Response Office
  • Category A highest priority
  • Category B second highest priority
  • Category C third highest priority

28
Weaponization of Agents
  • Alter characteristics of a pathogen to make it a
    more effective weapon
  • Enhance transmission
  • Increase virulence
  • Resistant to antibiotics
  • Evade vaccine protection
  • Alter clinical signs

29
Note to presenter
  • As time allows select diseases you would like to
    review.
  • If you have limited time you should focus on the
    Category A agents.
  • The disease coverage is brief. If you would like
    more information on a disease refer to the fact
    sheet or to the disease specific presentation.

30
Category A Agents/Diseases
  • Anthrax
  • Botulism
  • Plague
  • Smallpox
  • Tularemia
  • Viral Hemorrhagic fevers

31
Anthrax The Agent
  • Bacteria Bacillus anthracis
  • Forms spores
  • Human disease
  • Skin
  • Intestinal
  • Inhalational
  • Animal disease
  • Septicemia and rapid death

32
Anthrax The Bioweapon
  • History
  • Available easy to produce
  • Spores infective
  • Aerosolization
  • Low lethal dose
  • High mortality
  • Person-to-person transmission rare

33
Anthrax The Response
  • Vaccine
  • Humans
  • Animals
  • Antibiotics
  • Treatment
  • Prophylaxis
  • Disinfection
  • Sporicidal agents, sterilization

34
Botulism The Agent
  • Clostridium botulinum Gram pos, spore-forming
    bacteria
  • 7 different neurotoxins
  • Types A-G
  • Clinical signs
  • Flaccid paralysis
  • Pigs, dogs, and cats fairly
    resistant

35
Botulism The Bioweapon
  • Used by Aum Shinrikyo cult in Japan
  • Aerosolized
  • Easy to produce and transport
  • Potent and lethal
  • Most poisonous substance known

36
Botulism The Response
  • Toxoids for high risk people
  • Antitoxin available
  • Case-by-case basis
  • Botulinum toxins are easily inactivated with many
    disinfectants and heat

37
Plague The Agent
  • Yersinia pestis
  • Gram neg, transmitted by fleabites, aerosol,
    direct contact
  • Symptoms humans
  • Bubonic, septicemia, pneumonic
  • Symptoms animals
  • Cat similar to human
  • Dogs, livestock somewhat resistant

38
Plague The Bioweapon
  • WHO estimate
  • 50kg agent city population 5 million
  • 150,000 cases pneumonic plague
  • Potential mortality 100,000
  • Available
  • Person-to-person transmission
  • Pneumonic form 100 fatal if untreated

39
Plague The Response
  • Antibiotics generally effective if given early
  • Killed vaccine available
  • Isolation of sick individuals
  • Susceptible to a number of common disinfectants

40
Smallpox The Agent
  • Variola virus, Orthopoxvirus
  • Eradicated from the world in 1977
  • Narrow host range humans only
  • Transmission person-to-person, fomites
  • Clinical signs
  • Flu-like, progressive skin eruptions

41
Smallpox The Bioweapon
  • Disease signals a bioterrorism event
  • Large scale production
  • Aerosolization, susceptible population
  • Person to person and fomite transmission
  • Fatality approximately 35

42
Smallpox The Response
  • No specific treatment
  • Vaccinia virus vaccination
  • Vaccinia Immune Globulin
  • Isolation of infected individuals
  • Disinfection of environment, clothing etc. with
    various chemicals, boiling or autoclaving.

43
Tularemia The Agent
  • Francisella tularensis
  • Transmitted by ingestion, inhalation, vectors,
    direct contact through skin
  • Six clinical forms in humans

44
Tularemia The Agent
  • Sheep, young pigs, horses, dogs, cats
  • Sudden fever, lethargy, stiffness, prostration,
    and death
  • Wildlife
  • Usually find dead
  • Rabbits behave strangely
  • Cattle, older pigs resistant

45
Tularemia The Bioweapon
  • WHO estimation 1970
  • 50 kg agent city population 5 million
  • 250,000 ill
  • 19,000 deaths
  • Stable
  • Aerosolized
  • Low infective dose via inhalation
  • Mortality 21-49 if untreated

46
Tularemia The Response
  • Person to person transmission not documented
  • Antibiotics effective if early or prophylactic
  • Vaccine
  • For high risk individuals
  • Unknown efficacy
  • against inhalation
  • tularemia

47
Viral Hemorrhagic FeversThe Agents
  • Ebola, Marburg, Lassa, and Machupo
  • Human clinical presentation
  • Early fever, fatigue
  • Severe bleed from internal organs, body orifices
  • Progression to shock seizures
  • Animals only non-human primates susceptible

Vincent Massey
48
VHF The Bioweapons
  • Aerosolized
  • Not readily available, require specialized
    production
  • Person-to-person and nosocomial transmission
    occur
  • Untreated fatality rate estimated to be 50-90

49
VHF The Response
  • Intensive supportive care
  • Ribavirin has shown some efficacy
  • Susceptible to bleach solutions, phenolic
    disinfectants, and UV light

50
Category B Agents/Diseases
  • Brucellosis
  • Glanders
  • Melioidosis
  • Psittacosis
  • Q Fever
  • Typhus fever
  • Viral encephalitis
  • Toxins
  • Food Safety Threats
  • Water Safety Threats

51
Brucellosis The Agent
  • Gram negative bacteria
  • Ingestion, inhalation, or direct contact
  • Clinical signs
  • Humans cyclic fever and flu-like symptoms
  • Animals reproductive signs

52
Brucellosis The Agent
53
Brucellosis The Bioweapon
  • History
  • Aerosolization, highly infectious
  • Stable when lyophilized
  • Case fatality rate 0.5
  • Person to person unlikely
  • Incubation is variable making diagnosis difficult

54
Brucellosis The Response
  • Long term antibiotics generally effective
  • Vaccinate calves, no human vaccine
  • Eliminate reservoir
  • Standard precaution to avoid
    exposure
  • Thorough disinfection

55
Glanders The Agent
  • Burkholderia mallei Gram negative
  • Transmission by ingestion,
    inhalation, or direct contact
  • Animal-to-human transmission is
    inefficient
  • Clinical signs
  • Humans horses cutaneous pulmonary lesions,
    rapidly fatal illness

56
Glanders The Bioweapon
  • History
  • WWI Russian horses
  • WWII Chinese civilians, horses, POWs
  • Easy to reproduce, lyophilized
  • Aerosolized, highly infectious
  • Mortality high in chronic form
  • 50-70
  • Person to person transmission - rare

57
Glanders The Response
  • No vaccine
  • Antibiotic therapy likely effective
  • Destroyed by various chemicals

58
Melioidosis The Agent
  • Burkholderia pseudomallei Gram negative
  • Transmission contact, ingestion, inhalation
  • Clinical signs humans, sheep, goats, and pigs
  • Asymptomatic to pneumonia, lung wound
    abscesses

59
Melioidosis The Bioweapon
  • Easy to produce
  • Available
  • Aerosolization
  • Mortality high 90
  • Person-to-person transmission unlikely

60
Melioidosis The Response
  • Long term, multiple antibiotics effective
  • Vaccines available not in U.S.
  • Easily destroyed by disinfectants

61
Psittacosis The Agent
  • Chlamydophila psittaci
  • Occurs worldwide
  • Reportable in U.S.
  • Clinical disease
  • Humans and birds ranges from asymptomatic to
    systemic illness with severe pneumonia

62
Psittacosis The Bioweapon
  • Easily obtained
  • Aerosolized
  • Stable in the environment
  • Person-to-person transmission rare
  • Low mortality

63
Psittacosis The Response
  • Antibiotics generally effective
  • Decontamination with most disinfectants

64
Q Fever The Agent
  • Coxiella burnetii
  • Transmission inhalation, direct
    contact, ingestion, ticks
  • Disease symptoms
  • Humans
  • Acute flu-like pneumonia hepatitis
  • Chronic endocarditis, osteomyelitis
  • Animals most asymptomatic
  • Sheep, cattle and goats abortions

65
Q Fever The Bioweapon
  • History
  • Easily accessible, resistant
  • Highly infectious
  • Aerosolization
  • Low mortality

66
Q Fever The Response
  • Antibiotic therapy may limit complications
  • Vaccine developed, not available in U.S.
  • Variable susceptibility to disinfectants

67
Typhus Fever The Agent
  • Rickettsia prowazekii a rickettsial organism
  • Endemic in Eastern Europe, Middle East, and parts
    of Africa
  • Transmitted by excreta of human body louse
  • Clinical signs humans
  • Fever, headache, macular eruptions, and petechial
    rash
  • Not seen in domestic animals

J. Kalisch
68
Typhus Fever The Bioweapon
  • WHO estimation 1970
  • 50 kg agent 5 million people in city
  • 125,000 ill
  • 8,000 deaths
  • Available
  • Can be aerosolized in
    lice feces

U.S. Typhus Commission
69
Typhus Fever The Response
  • Antibiotics are generally effective
  • Vaccine, not commercially available

70
Viral Encephalitis The Agent
  • The alphaviruses EEE, WEE, and VEE
  • Transmitted via mosquito
  • Clinical signs
  • Birds are asymptomatic carriers, act as sentinels
  • Humans, horses, donkeys, mules often
    asymptomatic to flu-like
  • Encephalitis in small proportions

71
Viral EncephalitisThe Bioweapon
  • Easy to produce
  • Aerosolization
  • High rate of infection
  • Person-to-person transmission possible

72
Viral EncephalitisThe Response
  • Supportive care
  • Vaccine
  • Equine
  • Human high risk
  • Virus unstable in environment

73
Toxins The Agents
  • Staphylococcal enterotoxin B (SEB)
  • Ricin toxin from castor plant
  • Clostridium perfringens epsilon toxin

74
SEB The Agent
  • Staphylococcal enterotoxin B (SEB)
  • A common cause of food poisoning
  • Clinical signs humans
  • Fever, chills, headache, myalgia
  • Non-productive cough if inhaled
  • GI signs if swallowed
  • Animals likely similar to human

75
Ricin The Agent
  • Ricin toxin from bean of castor plant
  • Available worldwide
  • Clinical signs
  • Acute onset of fever,
  • chest tightness, cough,
  • dyspnea, nausea

76
Epsilon Toxin The Agent
  • Clostridium perfringens type B and D
  • Increases intestinal and vascular permeability,
    and liver damage
  • Clinical signs
  • Calves diarrhea, abdominal pain, listlessness,
    neurologic
  • Sheep, goats watery to bloody diarrhea,
    neurologic
  • Humans little information

77
Toxins The Bioweapon
  • History
  • Aerosolized SEB, Ricin
  • Available worldwide
  • Easy to produce, stable
  • Many species affected
  • No person-to-person transmission

78
Toxins The Response
  • Supportive
  • No vaccines currently available for SEB or Ricin
  • Vaccines for animals for clostridial disease
  • Toxins are inactivated with common disinfectants

79
Food Safety Threats
  • Campylobacter species
  • Salmonella species
  • E. coli 0157H7
  • Viruses, parasites, chemicals, toxins
  • Ingestion of contaminated food
  • Gastrointestinal upset

80
Food Safety Threats The Bioweapon
  • 1984, The Dalles, Oregon
  • Bagwan Shree Rajneesh cult
  • Contaminated salad bars
  • Salmonella typhimurium
  • Goal incapacitate voters
  • 751 people ill

81
Food Safety Threats The Response
  • Constant vigilance to improve food safety
  • Food irradiation at processing plants
  • Wash hands and utensils frequently
  • Proper cooking temperature and storage

82
Water Safety Threats
  • 53 of US drinking water is from ground water
  • Cryptosporidium parvum- protozoa
  • Vibrio cholerae- bacteria

83
Cryptosporidium The Agent
  • Cryptosporidium parvum- protozoa
  • Transmission inhalation, ingestion
  • Clinical signs humans, calves, others
  • Acute gastroenteritis
  • Dogs, cats, horses, pigs resistant

84
Vibrio cholerae The Agent
  • Vibrio cholerae- Gram negative bacteria
  • Transmission fecal-oral, contaminated shellfish
  • Clinical signs, humans
  • Acute, mild diarrhea
  • 5 severe disease
  • Animals are resistant to disease

85
Water Safety Public Health Significance
  • 1993 Municipal water supply contaminated in
    Milwaukee
  • Cryptosporidum parvum
  • 40,000 ill
  • 1997 Decorative water fountain at the Minnesota
    Zoo
  • 369 cases
  • Mostly young children

86
Water Safety Threats The Response
  • Government has laws to protect our water supply
  • Treatment facilities are equipped and will likely
    inactivate most organisms
  • Chlorination, filtration, ozone
  • Dilution factor

87
Category C
  • Nipah virus
  • Hantavirus

88
Nipah Virus The Agent
  • Paramyxovirus
  • Fruit bats
  • Clinical signs
  • Humans encephalitis
  • Pigs respiratory neurological
  • Dogs and cats distemper

89
Nipah Virus The Bioweapon
  • Aerosolization potential
  • Wide host range
  • No person to person transmission expected
  • High morbidity and mortality

90
Nipah Virus The Response
  • Avoid contact with all infected animals and
    fluids
  • Vaccine undergoing research
  • Call authorities immediately

91
Hantavirus The Agent
  • Bunyaviridae family
  • Asymptomatic reservoir rodents
  • Transmission inhalation, ingestion, direct
    contact
  • Human clinical signs
  • Fever, myalgia, headache
  • Hantavirus Pulmonary Syndrome
  • Hemorrhagic Fever with Renal Syndrome
  • Not seen in domestic animals

92
Hantavirus The Bioweapon
  • Aerosolized
  • Hospitalization
  • Hemorrhagic Fever with Renal Syndrome not the
    clinical form expected in U.S.

93
Hantavirus The Response
  • Supportive care
  • Limit exposure to rodent excrement
  • Virus is deactivated with bleach

94
Other Important Diseases
  • Transmissible Spongiform Encephalopathy
  • Rift Valley Fever
  • Hendra Virus
  • West Nile Virus
  • Foot and Mouth Disease

95
Transmissible Spongiform Encephalopathy The Agent
  • Prions
  • Proteinaceous infectious particles
  • Mutated proteins
  • Very long incubation period
  • Neurological signs in all species
  • No treatment available

96
Bovine Spongiform Encephalopathy
  • Mad cow disease
  • Incubation 2 to 8 years
  • 1995, United Kingdom
  • vCJD
  • People exposed to BSE
  • Before bovine offal ban in 1989
  • Active U.S. surveillance
  • No reported cases

97
TSE The Response
  • Very resistant
  • Heat, sterilization and disinfectants
  • Early identification not possible
  • Lack of host immune response
  • Long incubation period
  • No effective treatment or vaccine
  • Surveillance program
  • Import restrictions

98
Rift Valley Fever The Agent
  • Phlebovirus in family Bunyaviridae
  • Transmission mosquito, inhalation, contact with
    infected body fluids
  • Clinical signs
  • Humans flu-like, fever, headache
  • Severe disease retinitis, hemorrhagic
    fever
  • Animals abortions, death in neonates

99
Rift Valley Fever The Bioweapon
  • WHO estimate 1970
  • 50 kg of virus aerosolized
  • 35,000 incapacitated
  • 400 deaths (1 mortality)
  • Stable at most temperatures
  • Inactivated by various chemicals

100
Rift Valley Fever The Response
  • Vaccinate ruminants in endemic areas
  • Control mosquitoes
  • Avoid contact with infected tissues blood
  • Wear protective clothing
  • No person-to-person transmission

101
Hendra Virus The Agent
  • Newly discovered
  • Australia
  • Fruit bats
  • Transmission urine, body fluids
  • Incubation 6-18 days
  • Humans
  • Flu-like illness, respiratory failure
  • Horses, cats
  • Acute respiratory signs, nasal discharge, fever,
    encephalitis, sudden death

102
Hendra Virus The Response
  • Little is known about disease
  • Biolevel-4
  • Potentially serious consequences
  • High mortality rate
  • Lack of treatment

103
West Nile Virus The Agent
  • Flavivirus
  • Transmission
  • Mosquitoes Culex species
  • Blood transfusion, organ donation, breast feeding
  • Animals Horses, birds, mammals, and reptiles
  • Humans
  • Duration 3-6 days
  • 80 have no signs
  • 20 develop West Nile Fever

104
West Nile Virus Public Health Significance
  • Human illness in US in 2002
  • 4156 cases, 284 deaths
  • Horses illness in US in 2002
  • 14,717 cases
  • 40 of ill result in death
  • Method of introduction to U.S. unknown
  • data current as of 5/28/03

105
Map courtesy of CDC
106
West Nile Virus The Response
  • Treatment supportive care
  • Vaccine available for horses, not humans
  • Source elimination
  • Eliminate larval habitats
  • Personal protection
  • Reduce time outdoors
  • Wear long pants and sleeves
  • Use mosquito repellent

107
Foot and Mouth Disease FMD
  • Picornavirus
  • Transmission direct contact, aerosol, fomites
  • Species cloven-hooved animals (not horses)
  • Signs fever, vesicles, salivation, lameness
  • Extremely rare, mild symptoms in people

108
FMD Agroterrorism Threat
  • Most important livestock disease in the world
  • U.S. agriculture as a target
  • One sixth of the U.S. domestic product is tied to
    agriculture
  • Immunologically naive population
  • Vulnerabilities

109
FMD The Response
  • USDA upgrading safeguarding measures
  • Strict biosecurity
  • Notify authorities immediately
  • Response and recovery plans
  • Quarantine
  • Depopulation
  • Disinfection
  • Vaccination complex decision

110
The Veterinarians Responsibility
111
Opportunities for the Veterinary Profession
  • Integrate into the public health system
  • Be aware, contribute, assist in development of
    surveillance programs
  • Report trends in disease and clinical signs
  • Be involved with emergency response plans at all
    levels

112
The Veterinarians Responsibility
  • Guardian of animal and public health
  • Sharpen awareness of potential bioterrorism
  • Alert officials early
  • You are the expert
  • Provide leadership and input to clients and
    community

113
What to do if bioterrorism is suspected
  • Stay informed and remain calm
  • Response is event specific
  • Response is everyone's responsibility
  • Follow the advice of public health officials
  • Follow federal and state guidelines
  • Movement restrictions may be necessary

114
Contacts
  • Phone numbers to know
  • State Veterinarian
  • State Public Health Veterinarian
  • APHIS- Area Veterinarian in Charge
  • Public Health Officials

115
Summary
  • Bioterrorism is a real threat
  • Public health infrastructure is being
    strengthened
  • Many bioterrorism agents are zoonotic.
  • Awareness education is important component of
    preparedness and protection

116
Summary
  • Prevention, recognition, and response involves
    everyone
  • Report any suspicious activity, unexplained
    behavior or death loss in your clients herd or
    flock
  • You play a critical role

117
Conclusion
  • The best prescription,
  • is knowledge.
  • Dr. C. Everett Koop
  • Former U.S. Surgeon General

118
Acknowledgments
  • Development of this presentation was funded by a
    grant from the Centers for Disease Control and
    Prevention to the Center for Food Security and
    Public Health at Iowa State University.

Authors Danelle Bickett-Weddle, DVM Jamie
Snow, DVM Reviewers Radford G. Davis, DVM, MPH
Gayle B. Brown, DVM, PhD
Write a Comment
User Comments (0)
About PowerShow.com